Schuler P J, Boehm F, Schild L R, Greve J, Hoffmann T K
Klinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie, Universitätsklinikum Ulm, Frauensteige 12, 89075, Ulm, Deutschland.
i2SOUL Consortium, Surgical Oncology Ulm, Ulm, Deutschland.
HNO. 2021 Feb;69(2):131-139. doi: 10.1007/s00106-020-00934-w.
Robot-assisted surgery (RAS) has already been approved for several clinical applications in head and neck surgery. In some Anglo-American regions, RAS is currently the common standard for treatment of oropharyngeal diseases. Systematic randomized studies comparing established surgical procedures with RAS in a large number of patients are unavailable so far. Experimental publications rather describe how to reach poorly accessible anatomical regions using RAS, or represent feasibility studies on the use of transoral robotic surgery (TORS) in established surgical operations. With general application of RAS in clinical practice, the question of financial reimbursement arises. Furthermore, the technical applications currently on the market still require some specific improvements for routine use in head and neck surgery.
机器人辅助手术（RAS）已被批准用于头颈外科的多种临床应用。在一些英美地区，RAS目前是治疗口咽疾病的常用标准。迄今为止，尚无系统的随机研究将成熟的外科手术与RAS在大量患者中进行比较。实验性出版物更多地描述了如何使用RAS到达难以触及的解剖区域，或者是关于在既定外科手术中使用经口机器人手术（TORS）的可行性研究。随着RAS在临床实践中的广泛应用，出现了费用报销的问题。此外，目前市场上的技术应用在头颈外科的常规使用中仍需要一些具体改进。
